Wang, Xinru
Nanjing Medical University,
China
2023 Rank: 236083
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1024 out of 61487 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 236083 | 261758 |
| Total Cites | 1209 | 1255 |
| H-index | 12 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 3 | 3 |
| Number of Single+First+Last Authored Papers | 213 | 213 |
| Total Cites to Single+First+Last Authored Papers | 496 | 502 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1059 | 1089 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.15 |
| Self-Citation Percentage |
3.67%
|
|
Wang, Xinru
Nanjing Medical University,
China
2022 Rank: 205311
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 890 out of 55990 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 205311 | 231316 |
| Total Cites | 1137 | 1183 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 3 | 3 |
| Number of Single+First+Last Authored Papers | 211 | 211 |
| Total Cites to Single+First+Last Authored Papers | 542 | 554 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 952 | 981 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.21 |
| Self-Citation Percentage |
3.89%
|
|
Wang, Xinru
Nanjing Medical University,
China
2021 Rank: 204772
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 904 out of 53247 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 204772 | 236138 |
| Total Cites | 1702 | 1769 |
| H-index | 17 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 4 | 4 |
| Number of Single+First+Last Authored Papers | 207 | 207 |
| Total Cites to Single+First+Last Authored Papers | 834 | 855 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1441 | 1483 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.19 |
| Self-Citation Percentage |
3.79%
|
|
Wang, Xinru
Nanjing Medical University,
China
2020 Rank: 185014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Toxicology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 845 out of 45124 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 185014 | 197540 |
| Total Cites | 1208 | 1302 |
| H-index | 14 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 5 | 5 |
| Number of Single+First+Last Authored Papers | 196 | 196 |
| Total Cites to Single+First+Last Authored Papers | 655 | 690 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1021 | 1088 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
7.22%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.